99 related articles for article (PubMed ID: 1975317)
21. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
Cullinan SA; Moertel CG; Fleming TR; Rubin JR; Krook JE; Everson LK; Windschitl HE; Twito DI; Marschke RF; Foley JF
JAMA; 1985 Apr; 253(14):2061-7. PubMed ID: 2579257
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
Cantore M; Mambrini A; Fiorentini G; Rabbi C; Zamagni D; Caudana R; Pennucci C; Sanguinetti F; Lombardi M; Nicoli N
Cancer; 2005 Apr; 103(7):1402-7. PubMed ID: 15726542
[TBL] [Abstract][Full Text] [Related]
23. Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma.
Raymond E; de Gramont A; Louvet C; Tournigand C; Demuynck B; Beerblock K; Carola E; Krulik M
Eur J Cancer; 1997 Apr; 33(4):696-7. PubMed ID: 9274458
[No Abstract] [Full Text] [Related]
24. A phase II study of sequential methotrexate and 5-fluorouracil in metastatic pancreatic cancer.
Ikeda M; Okada S; Ueno H; Okusaka T; Tanaka N; Kuriyama H; Yoshimori M
Hepatogastroenterology; 2000; 47(33):862-5. PubMed ID: 10919048
[TBL] [Abstract][Full Text] [Related]
25. Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.
Patt YZ; Hassan MM; Lozano RD; Waugh KA; Hoque AM; Frome AI; Lahoti S; Ellis L; Vauthey JN; Curley SA; Schnirer II; Raijman I
Clin Cancer Res; 2001 Nov; 7(11):3375-80. PubMed ID: 11705850
[TBL] [Abstract][Full Text] [Related]
26. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
Webb A; Cunningham D; Scarffe JH; Harper P; Norman A; Joffe JK; Hughes M; Mansi J; Findlay M; Hill A; Oates J; Nicolson M; Hickish T; O'Brien M; Iveson T; Watson M; Underhill C; Wardley A; Meehan M
J Clin Oncol; 1997 Jan; 15(1):261-7. PubMed ID: 8996151
[TBL] [Abstract][Full Text] [Related]
27. A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers.
Ciuleanu T; Diculescu M; Hoepffner NM; Trojan J; Sailer V; Zalupski M; Herrmann T; Roth A; Chick J; Brock K; Albert D; Philip PA
Invest New Drugs; 2007 Aug; 25(4):385-90. PubMed ID: 17364234
[TBL] [Abstract][Full Text] [Related]
28. 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract.
Harvey JH; Smith FP; Schein PS
J Clin Oncol; 1984 Nov; 2(11):1245-8. PubMed ID: 6092556
[TBL] [Abstract][Full Text] [Related]
29. FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience.
Moretto R; Raimondo L; De Stefano A; Cella CA; Matano E; De Placido S; Carlomagno C
Anticancer Drugs; 2013 Oct; 24(9):980-5. PubMed ID: 23928570
[TBL] [Abstract][Full Text] [Related]
30. Sequential methotrexate, 5-fluorouracil (high-dose), and doxorubicin for advanced gastric cancer.
Muro H; Acuña LR; Castagnari A; Blajman C; Schmilovich A; Hidalgo A; Fiori H; Bader M; Marantz A
Cancer Treat Rep; 1986 Nov; 70(11):1333-4. PubMed ID: 3768875
[No Abstract] [Full Text] [Related]
31. [5 years' results of a CMF protocol (methotrexate, cyclophosphamide, fluorouracil) of adjuvant chemotherapy in breast cancers].
Horner-Vallet D; Cappelaere P; Delobelle A; Depadt G; Madelain M; Demaille A
LARC Med; 1984 Nov; 4(9):532-40. PubMed ID: 6549038
[No Abstract] [Full Text] [Related]
32. [Changes in chemotherapy for pancreatic adenocarcinoma].
Hammel P
Gastroenterol Clin Biol; 2002; 26(6-7):603-4. PubMed ID: 12193859
[No Abstract] [Full Text] [Related]
33. Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer.
Morizane C; Okada S; Okusaka T; Ueno H; Saisho T
Oncology; 2003; 64(4):475-6. PubMed ID: 12759549
[No Abstract] [Full Text] [Related]
34. Combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-fluorouracil in solid tumors.
Costanzi JJ; Coltman CA
Cancer; 1969 Mar; 23(3):589-96. PubMed ID: 4304025
[No Abstract] [Full Text] [Related]
35. Advanced pancreatic cancer--5 years on.
Rao S; Cunningham D
Ann Oncol; 2002 Aug; 13(8):1165-8. PubMed ID: 12181237
[No Abstract] [Full Text] [Related]
36. Ifosfamide plus 5-fluorouracil for treatment of adenocarcinoma of the pancreas.
Loehrer PJ; Williams SD; Nichols CR
Cancer Treat Rep; 1987 Nov; 71(11):1115-6. PubMed ID: 3119208
[No Abstract] [Full Text] [Related]
37. [Chemotherapy in adenocarcinomas of the pancreas].
Huguier M
Gastroenterol Clin Biol; 2002 Nov; 26(11):1063; discussion 1063-4. PubMed ID: 12483149
[No Abstract] [Full Text] [Related]
38. [A case of unresectable pancreatic cancer responding to MTX/5-FU sequential therapy].
Takahashi N; Masamune R; Kunii Y
Gan To Kagaku Ryoho; 1999 Jan; 26(1):153-5. PubMed ID: 9987514
[TBL] [Abstract][Full Text] [Related]
39. [A case report of preoperative intra-arterial infusion chemotherapy for pancreatic head carcinoma].
Ohigashi H; Ishikawa O; Sasaki Y; Nakano H; Nakamori S; Kameyama M; Hiratsuka M; Kabuto T; Furukawa H; Yasuda T; Imaoka S; Fujita M; Kuroda C
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1825-8. PubMed ID: 9382542
[TBL] [Abstract][Full Text] [Related]
40. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
